Tscan Therapeutics Inc (TCRX)
1.5300 x 1 1.6600 x 2
Pre-market by (Cboe BZX)
1.6000 -0.0700 (-4.19%) 03/24/25 [NASDAQ]
1.5300 x 1 1.6600 x 2
Pre-market 1.6000 unch (unch) 16:00 ET
for Mon, Mar 24th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,499 | -89,218 | -66,221 | -48,625 | -26,127 |
| Depreciation Amortization | 4,108 | 5,361 | 5,137 | 3,328 | 1,230 |
| Accounts payable and accrued liabilities | 1,994 | -52 | 528 | 10 | 1,127 |
| Other Working Capital | 5,054 | 17,606 | -10,230 | -5,896 | 21,357 |
| Other Operating Activity | 5,521 | 4,945 | 4,283 | 2,506 | -610 |
| Operating Cash Flow | $-110,822 | $-61,358 | $-66,503 | $-48,677 | $-3,023 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,825 | -3,146 | -4,225 | -9,941 | -4,238 |
| Purchase Of Investment | -241,445 | -77,613 | N/A | N/A | N/A |
| Sale Of Investment | 192,657 | 20,000 | N/A | N/A | N/A |
| Investing Cash Flow | $-52,613 | $-60,759 | $-4,225 | $-9,941 | $-4,238 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 32,457 | N/A | 29,354 | N/A | N/A |
| Debt Repayment | -17,144 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 193,452 | 135,443 | 326 | 89,938 | 288 |
| Other Financing Activity | 0 | 0 | -324 | 99,730 | 0 |
| Financing Cash Flow | $208,765 | $135,443 | $29,356 | $189,668 | $288 |
| Beginning Cash Position | 138,390 | 125,064 | 166,436 | 35,386 | 42,359 |
| End Cash Position | 183,720 | 138,390 | 125,064 | 166,436 | 35,386 |
| Net Cash Flow | $45,330 | $13,326 | $-41,372 | $131,050 | $-6,973 |
| Free Cash Flow | |||||
| Operating Cash Flow | -110,822 | -61,358 | -66,503 | -48,677 | -3,023 |
| Capital Expenditure | -3,825 | -3,146 | -4,225 | -9,941 | -4,238 |
| Free Cash Flow | -114,647 | -64,504 | -70,728 | -58,618 | -7,261 |